EMA launches Website for accelerating EU Clinical Trials
Recommendation

Thursday, 29 October 2026 9 .00 - 17.15 h
AI/ML-based Methods for Optimizing Pharmaceutical Research Processes
The EMA has launched a dedicated website for the Accelerating clinical trials in the European Union (ACT EU) initiative, co-led by the European Commission, the Heads of Medicines Agencies and the European Medicines Agency (EMA). The website contains updates on the progress of ACT EU priority actions, which aim to improve the clinical trials environment in the EU through harmonization, innovation, and stakeholder collaboration.
Key resources include latest information on:
- the Multi-stakeholder platform;
- the implementation of the Clinical Trials Regulation (CTR);
- voluntary procedures in scientific advice;
- the Simultaneous national scientific advice (SNSA) pilot.
In addition, the EMA held a workshop on establishing a multi-stakeholder platform on 22/23 June 2023. Following the workshop, the presentations shown and also the video recordings were published on the EMA website about the workshop.
Related GMP News
05.10.2026FDA: Next Step to Reduce Animal Based Testing Methods
23.09.2026FDA Publishes Draft Guidance on Potency Testing of Active Immunotherapy Products
27.08.2026EMA publishes Consolidated ICH E6(R3) Guideline
28.07.2026WHO publishes GCP Guidelines for Comment
09.07.2026Final ICH E6(R3) Annex 2


